UAB Sanobiotec Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 4,378,340 |
| 150,458 |
| 155,770 |
| 118,633 |
| 4,077 |
| 33.91 |
| 2.71 |
| 1,019,037 |
| 1,239,469 |
| 311,954 |
| 1,946,552 |
| 2024 |
|---|
| 5,141,439 |
| 148,768 |
| 114,647 |
| 76,462 |
| 2,212 |
| 27.93 |
| 1.49 |
| 1,095,500 |
| 1,248,252 |
| 375,307 |
| 1,968,445 |
| 2025 |
|---|
| 3,556,556 |
| 135,591 |
| -547,110 |
| -461,493 |
| -17,594 |
| 14.60 |
| -12.98 |
| 632,131 |
| 1,159,528 |
| 359,421 |
| 1,432,238 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 3,556,556 |
| 135,591 |
| -547,110 |
| -461,493 |
| -17,594 |
| 14.60 |
| -12.98 |
| 632,131 |
| 1,159,528 |
| 359,421 |
| 1,432,238 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
3,556,556 €-31 % *
Sales per employee (€)
135,591 €-9 % *
Profit before tax (€)
-547,110 €-577 % *
Net Profit (€)
-461,493 €-704 % *
Profit per employee (€)
-17,594 €-895 % *
Total profitability (%)
14.60 %-47.73 % *
Net profitability (%)
-12.98 %-971.14 % *
Equity (€)
632,131 €-42 % *
Amounts Payable And Liabilities (€)
1,159,528 €-7 % *
Non-current Assets (€)
359,421 €-4 % *
CurrentAssets (€)
1,432,238 €-27 % *
